In summary, semaglutide has proven to be a pinnacle of GLP-1 drug development so far: highly efficacious for glycemic control, capable of inducing substantial weight loss, and demonstrating broad benefits (cardiovascular, renal, and beyond)
The meta-analytic evidence is clear that subgroup nuances matter enormously
Any licensed health care providerincluding primary care physicians, nurse practitioners, physician assistants, and specialists such as endocrinologists, cardiologists, and gastroenterologistscan prescribe GLP-1 medications
Its levels, however, can be depleted by factors such as poor nutrition, environmental toxins, and stress